- Research works
- 13 ▼ 30% vs 2018-21
- Citations
- 1.2k 94.8 per fractional work
- Top-10% rate
- 18.9% all institutions 10.0%
- Open access
- 38% world 40%
- International
- 33% world 18%
Not ranked overall: ANZCHOG is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does ANZCHOG work in?
In all years, 65% of research at ANZCHOG is in Health Sciences, 14% in Physical Sciences. Its largest fields are Medicine (56%), Health Professions (9%), Physics and Astronomy (8%). It does 1.9× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 12 fields, with their numbers
- Health Sciences865.0%
- Medicine756.2%
- Health Professions18.8%
- Physical Sciences214.4%
- Physics and Astronomy17.9%
- Computer Science03.9%
- Chemical Engineering00.9%
- Engineering00.9%
- Materials Science00.9%
- Social Sciences212.0%
- Life Sciences18.6%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Who are the top researchers at ANZCHOG?
Ranked on the quality score, Robyn Strong lead among researchers whose main affiliation is ANZCHOG.
- 1
Robyn Strong
Australia · #3,455,152 worldwide 94 citations · 17 works
Which research topics does ANZCHOG publish most on?
By volume in 2022-now: Acute Lymphoblastic Leukemia research, Acute Myeloid Leukemia Research, Glioma Diagnosis and Treatment and Chronic Myeloid Leukemia Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 0 works
- 2 Acute Myeloid Leukemia Research Hematology 0 works
- 3 Glioma Diagnosis and Treatment Genetics 0 works
- 4 Chronic Myeloid Leukemia Treatments Hematology 0 works
- 5 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 6 Pancreatic and Hepatic Oncology Research Oncology 0 works
- 7 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 0 works
- 8 Ubiquitin and proteasome pathways Molecular Biology 0 works
- 9 Protein Degradation and Inhibitors Molecular Biology 0 works
- 10 Sarcoma Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has ANZCHOG's research output changed?
Output in 2022-2025 was 30% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is ANZCHOG as a percentage of every work published that year, 0.0000090% in 2024.
Fractional works of ANZCHOG over all fractional works that year. How the balance of science has shifted.
Other research institutions in Clayton
- Monash Institute of Medical Research
- Hudson Institute of Medical Research
- Robert Bosch (Australia)
- Australian National Fabrication Facility
- Melbourne Centre for Nanofabrication
- ARC Centre of Excellence in Future Low-Energy Electronics Technologies
- Jean Hailes
- Cooperative Research Centre for Water Sensitive Cities
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about ANZCHOG. Posts are plain text and can be reported.